Injection of Recombinant Human Tissue-type Plasminogen Activator Derivative for Acute Pulmonary Embolism(rPA)

NCT04110275 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

174

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Pulmonary Embolism

Interventions

DRUG: Recombinant human tissue-type plasminogen activator derivative
DRUG: Recombinant human tissue-type plasminogen activator

Sponsor

Angde Biotech Pharmaceutical Co., Ltd.